EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mucus Plug Score Predicts Clinical and Pulmonary Function Response to Biologic Therapy in Patients With Severe Asthma

Jeremias Götschke, Julia Walter, Gabriele Leuschner, Michael Gerckens, Melanie Götschke, Pontus Mertsch, Carlo Mümmler, Alexandra Lenoir, Michaela Barnikel, Julien Dinkel, Jürgen Behr, Nikolaus Kneidinger und 2 weitere

The Journal of Allergy and Clinical Immunology: In Practice · 2025-05 · 13 (5) · 1110-1122.e1

DOI: 10.1016/j.jaip.2025.01.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2025-05. Verfasst von Jeremias Götschke und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine V, LMU University Hospital, LMU Munich, Munich, Germany; Comprehensive Pneumology Center Munich, German Center for Lung Resear…. Hauptthemen laut MEDLINE: Mucus, Asthma, Biological Products. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Mucus plugging has been identified as an important feature of severe asthma contributing to airway obstruction and disease severity. Recently, improvement in mucus plugging has been found on treatment with several biologic therapies. OBJECTIVES: To analyze associations of baseline characteristic with the mucus plugging score (MPS) and to determine whether the MPS at baseline predicts the clinical and functional response to biologic treatment in patients with severe asthma. METHODS: We retrospectively analyzed biologic-naive patients with a suitable computed tomography scan available at baseline. We calculated the MPS and analyzed correlations with baseline parameters and improvements in biomarkers, pulmonary function, and clinical parameters after 4 months of biologic therapy. RESULTS: We included 113 patients in the baseline cohort, 101 patients of whom had sufficient data after 4 months of biologic therapy for the follow-up analysis. Computed tomography showed mucus plugging in 77% of patients (median MPS, 4). Multivariate regression analysis showed a correlation of MPS with lower FEV1 (ρ = -0.24; P = .009) and diffusing capacity for carbon monoxide (ρ = -0.26; P = .01), and higher FeNO (ρ = .36; P = .0003) at baseline. Patients received treatment with anti-IgE (8.8%), anti-IL-5 (27.4%), anti-IL-5R (37.2%), anti-IL-4R (25.7%), and anti-thymic stromal lymphopoietin (0.9%) in clinical routine. Baseline MPS correlated with improvements in FEV1 (β = 0.72; P = .01) and Asthma Control Test (β = 0.24; P = .001) in multivariate regression analysis. CONCLUSION: Our study suggests that a higher MPS correlates with worse pulmonary function at baseline but also predicts a larger clinical and pulmonary function response to biologic therapies in severe asthma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MucusAsthmaBiological ProductsHumansMaleFemaleAdultMiddle AgedAgedSeverity of Illness IndexMagnetic Resonance ImagingTreatment OutcomeCarbon MonoxideNitric Oxide

Stichwörter der Autor:innen

AntibodyAsthmaBiologic therapyDiffusion capacityFEV(1)FeNOMucus plug scoreMucus pluggingPulmonary functionResponse

Substanzen

Biological ProductsCarbon MonoxideNitric Oxide

Autor:innen und Institutionen

  • Department of Medicine V, LMU University Hospital, LMU Munich, Munich, Germany; Comprehensive Pneumology Center Munich, German Center for Lung Research (DZL), Munich, Germany.
  • Department of Medicine V, LMU University Hospital, LMU Munich, Munich, Germany; Comprehensive Pneumology Center Munich, German Center for Lung Research (DZL), Munich, Germany; Institute of Lung Health and Immunity, Comp…
  • Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany, Member of the German Center for Lung Research (DZL).
  • Department of Medicine V, LMU University Hospital, LMU Munich, Munich, Germany; Comprehensive Pneumology Center Munich, German Center for Lung Research (DZL), Munich, Germany; Division of Pulmonology, Department of Inte…

Zitieren

APA

Götschke, J., Walter, J., Leuschner, G., Gerckens, M., Götschke, M., Mertsch, P., Mümmler, C., Lenoir, A., Barnikel, M., Dinkel, J., Behr, J., Kneidinger, N., Spiro, J. E., & Milger, K. (2025). Mucus Plug Score Predicts Clinical and Pulmonary Function Response to Biologic Therapy in Patients With Severe Asthma. The Journal of Allergy and Clinical Immunology: In Practice, 13(5), 1110-1122.e1. https://doi.org/10.1016/j.jaip.2025.01.010

Vancouver

Götschke J, Walter J, Leuschner G, Gerckens M, Götschke M, Mertsch P, et al. Mucus Plug Score Predicts Clinical and Pulmonary Function Response to Biologic Therapy in Patients With Severe Asthma. The Journal of Allergy and Clinical Immunology: In Practice. 2025;13(5):1110-1122.e1. doi:10.1016/j.jaip.2025.01.010

BibTeX
@article{Gtschke2025,
  author = {Götschke, Jeremias and Walter, Julia and Leuschner, Gabriele and Gerckens, Michael and Götschke, Melanie and Mertsch, Pontus and Mümmler, Carlo and Lenoir, Alexandra and Barnikel, Michaela and Dinkel, Julien and Behr, Jürgen and Kneidinger, Nikolaus and Spiro, Judith Eva and Milger, Katrin},
  title = {Mucus Plug Score Predicts Clinical and Pulmonary Function Response to Biologic Therapy in Patients With Severe Asthma},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2025},
  volume = {13},
  number = {5},
  pages = {1110--1122.e1},
  doi = {10.1016/j.jaip.2025.01.010}
}
Kostenlos starten →